Bruna Scaggiante

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 21

Top Venues

International journal of molecular sciences

Pharmaceutics

Biomedicines

PloS one

University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University Oct 01 2003

Italy

Assistant Professor PhD :: Department of Life Sciences

University Oct 01 1990 - Sep 30 2003

Italy

Assistant Professor, PhD :: Department of Biomedical Sciences and Technologies

Publications

Marianna Maddaloni, Rossella Farra, Barbara Dapas, Fulvia Felluga, Fabio Benedetti, Federico Berti, Sara Drioli, Mattia Vidali, Maja Cemazar, Urška Kamenšek, Claudio Brancolini, Erminio Murano, Francesca Maremonti, Mario Grassi, Alice Biasin, Flavio Rizzolio, Enrico Cavarzerani, Bruna Scaggiante, Roberta Bulla, Andrea Balduit, Giuseppe Ricci, Gabriella Zito, Federica Romano, Serena Bonin, Eros Azzalini, Gabriele Baj, Domenico Tierno, Gabriele Grassi
In Vitro and In Vivo Evaluation of the Effects of Drug 2c and Derivatives on Ovarian Cancer Cells. Pharmaceutics 16 (5) (2024)
Domenico Tierno, Gabriele Grassi, Fabrizio Zanconati, Barbara Dapas, Bruna Scaggiante
Plasma Circular RNAs as Biomarkers for Breast Cancer. Biomedicines 12 (4) (2024)
Du-Bois Asante, Domenico Tierno, Michael Woode, Bruna Scaggiante
Angiogenesis and Ovarian Cancer: What Potential Do Different Subtypes of Circulating Endothelial Cells Have for Clinical Application? International journal of molecular sciences 25 (11) (2024)
Marianna Maddaloni, Rossella Farra, Barbara Dapas, Fulvia Felluga, Fabio Benedetti, Federico Berti, Sara Drioli, Mattia Vidali, Maja Cemazar, Urška Kamenšek, Claudio Brancolini, Erminio Murano, Francesca Maremonti, Mario Grassi, Alice Biasin, Flavio Rizzolio, Enrico Cavarzerani, Bruna Scaggiante, Roberta Bulla, Andrea Balduit, Giuseppe Ricci, Gabriella Zito, Federica Romano, Serena Bonin, Eros Azzalini, Gabriele Baj, Domenico Tierno, Gabriele Grassi
In Vitro and In Vivo Evaluation of the Effects of Drug 2c and Derivatives on Ovarian Cancer Cells. Pharmaceutics 16 (5) (2024)
Domenico Tierno, Gabriele Grassi, Fabrizio Zanconati, Barbara Dapas, Bruna Scaggiante
Plasma Circular RNAs as Biomarkers for Breast Cancer. Biomedicines 12 (4) (2024)
Du-Bois Asante, Domenico Tierno, Michael Woode, Bruna Scaggiante
Angiogenesis and Ovarian Cancer: What Potential Do Different Subtypes of Circulating Endothelial Cells Have for Clinical Application? International journal of molecular sciences 25 (11) (2024)
Marina Bortul, Fabiola Giudici, Domenico Tierno, Daniele Generali, Serena Scomersi, Gabriele Grassi, Cristina Bottin, Maria Rosa Cappelletti, Fabrizio Zanconati, Bruna Scaggiante
A Case-Control Study by ddPCR of ALU 260/111 and LINE-1 266/97 Copy Number Ratio in Circulating Cell-Free DNA in Plasma Revealed LINE-1 266/97 as a Potential Biomarker for Early Breast Cancer Detection. International journal of molecular sciences 24 (10) (2023)
Domenico Tierno, Gabriele Grassi, Fabrizio Zanconati, Marina Bortul, Bruna Scaggiante
An Overview of Circulating Cell-Free Nucleic Acids in Diagnosis and Prognosis of Triple-Negative Breast Cancer. International journal of molecular sciences 24 (2) (2023)
Francesco Claps, Nicola Pavan, Luca Ongaro, Domenico Tierno, Gabriele Grassi, Carlo Trombetta, Gabriele Tulone, Alchiede Simonato, Riccardo Bartoletti, Laura S Mertens, Bas W G van Rhijn, Maria Carmen Mir, Bruna Scaggiante
BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer: Current Treatment Landscape and Novel Emerging Molecular Targets. International journal of molecular sciences 24 (16) (2023)
Domenico Tierno, Gabriele Grassi, Fabrizio Zanconati, Marina Bortul, Bruna Scaggiante
An Overview of Circulating Cell-Free Nucleic Acids in Diagnosis and Prognosis of Triple-Negative Breast Cancer. International journal of molecular sciences 24 (2) (2023)
Domenico Tierno, Gabriele Grassi, Fabrizio Zanconati, Marina Bortul, Bruna Scaggiante
An Overview of Circulating Cell-Free Nucleic Acids in Diagnosis and Prognosis of Triple-Negative Breast Cancer. International journal of molecular sciences 24 (2) (2023)
Tanja Jesenko, Simona Kranjc Brezar, Maja Cemazar, Alice Biasin, Domenico Tierno, Bruna Scaggiante, Mario Grassi, Chiara Grassi, Barbara Dapas, Nhung Hai Truong, Michela Abrami, Fabrizio Zanconati, Deborah Bonazza, Flavio Rizzolio, Salvatore Parisi, Giorgia Pastorin, Gabriele Grassi
Targeting Non-Coding RNAs for the Development of Novel Hepatocellular Carcinoma Therapeutic Approaches. Pharmaceutics 15 (4) (2023)
Domenico Tierno, Gabriele Grassi, Fabrizio Zanconati, Marina Bortul, Bruna Scaggiante
An Overview of Circulating Cell-Free Nucleic Acids in Diagnosis and Prognosis of Triple-Negative Breast Cancer. International journal of molecular sciences 24 (2) (2023)
Tanja Jesenko, Simona Kranjc Brezar, Maja Cemazar, Alice Biasin, Domenico Tierno, Bruna Scaggiante, Mario Grassi, Chiara Grassi, Barbara Dapas, Nhung Hai Truong, Michela Abrami, Fabrizio Zanconati, Deborah Bonazza, Flavio Rizzolio, Salvatore Parisi, Giorgia Pastorin, Gabriele Grassi
Targeting Non-Coding RNAs for the Development of Novel Hepatocellular Carcinoma Therapeutic Approaches. Pharmaceutics 15 (4) (2023)
Domenico Tierno, Gabriele Grassi, Serena Scomersi, Marina Bortul, Daniele Generali, Fabrizio Zanconati, Bruna Scaggiante
Next-Generation Sequencing and Triple-Negative Breast Cancer: Insights and Applications. International journal of molecular sciences 24 (11) (2023)
Tanja Jesenko, Simona Kranjc Brezar, Maja Cemazar, Alice Biasin, Domenico Tierno, Bruna Scaggiante, Mario Grassi, Chiara Grassi, Barbara Dapas, Nhung Hai Truong, Michela Abrami, Fabrizio Zanconati, Deborah Bonazza, Flavio Rizzolio, Salvatore Parisi, Giorgia Pastorin, Gabriele Grassi
Targeting Non-Coding RNAs for the Development of Novel Hepatocellular Carcinoma Therapeutic Approaches. Pharmaceutics 15 (4) (2023)
Tanja Jesenko, Simona Kranjc Brezar, Maja Cemazar, Alice Biasin, Domenico Tierno, Bruna Scaggiante, Mario Grassi, Chiara Grassi, Barbara Dapas, Nhung Hai Truong, Michela Abrami, Fabrizio Zanconati, Deborah Bonazza, Flavio Rizzolio, Salvatore Parisi, Giorgia Pastorin, Gabriele Grassi
Targeting Non-Coding RNAs for the Development of Novel Hepatocellular Carcinoma Therapeutic Approaches. Pharmaceutics 15 (4) (2023)
Nadia Halib, Nicola Pavan, Carlo Trombetta, Barbara Dapas, Rossella Farra, Bruna Scaggiante, Mario Grassi, Gabriele Grassi
An Overview of siRNA Delivery Strategies for Urological Cancers. Pharmaceutics 14 (4) (2022)
Alessandra Bosutti, Barbara Dapas, Gabriele Grassi, Rossana Bussani, Fabrizio Zanconati, Fabiola Giudici, Cristina Bottin, Nicola Pavan, Carlo Trombetta, Bruna Scaggiante
High eEF1A1 Protein Levels Mark Aggressive Prostate Cancers and the In Vitro Targeting of eEF1A1 Reveals the eEF1A1-actin Complex as a New Potential Target for Therapy. International journal of molecular sciences 23 (8) (2022)
Federica Tonon, Rossella Farra, Cristina Zennaro, Gabriele Pozzato, Nhung Truong, Salvatore Parisi, Flavio Rizzolio, Mario Grassi, Bruna Scaggiante, Fabrizio Zanconati, Deborah Bonazza, Gabriele Grassi, Barbara Dapas
Xenograft Zebrafish Models for the Development of Novel Anti-Hepatocellular Carcinoma Molecules. Pharmaceuticals (Basel, Switzerland) 14 (8) (2021)
Fabiola Giudici, Elisabetta Petracci, Oriana Nanni, Cristina Bottin, Maurizio Pinamonti, Fabrizio Zanconati, Bruna Scaggiante
Elevated levels of eEF1A2 protein expression in triple negative breast cancer relate with poor prognosis. PloS one 14 (6) (2019)

Bruna Scaggiante.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Bruna Scaggiante